CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

NCT05013372 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

T-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: CD147- CAR T cells

Sponsor

Peking University People's Hospital